Share this article
Share this article
ALPHARETTA, Ga., Feb. 18, 2021 /PRNewswire/ Avanos Medical, Inc. (NYSE: AVNS) today reported fourth quarter and full-year 2020 results. I m pleased with our team s execution and accomplishments in 2020 highlighted by our cost savings, the integration of our recent acquisitions and free cash flow improvement throughout the year, while successfully responding to the challenges presented by the pandemic, stated Joe Woody, Avanos chief executive officer. During the quarter we continued to build momentum across our franchises, while we maintained our cost discipline and implemented a 2020 restructuring program to further drive efficiencies and reduce costs.
Woody continued, We enter 2021 in a strong position and are poised to execute on our plan to deliver top-line growth, drive margin improvement and generate free cash flow in 2021 and beyond.